329 related articles for article (PubMed ID: 31136822)
41. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.
Kaplan AP; Giménez-Arnau AM; Saini SS
Allergy; 2017 Apr; 72(4):519-533. PubMed ID: 27861988
[TBL] [Abstract][Full Text] [Related]
42. Upregulated expression of substance P in basophils of the patients with chronic spontaneous urticaria: induction of histamine release and basophil accumulation by substance P.
Zheng W; Wang J; Zhu W; Xu C; He S
Cell Biol Toxicol; 2016 Jun; 32(3):217-28. PubMed ID: 27147256
[TBL] [Abstract][Full Text] [Related]
43. Carboplatin-induced severe hypersensitivity reaction: role of IgE-dependent basophil activation and FcεRI.
Iwamoto T; Hirai H; Yamaguchi N; Kobayashi N; Sugimoto H; Tabata T; Okuda M
Cancer Sci; 2014 Nov; 105(11):1472-9. PubMed ID: 25230301
[TBL] [Abstract][Full Text] [Related]
44. Correlations between disease activity, autoimmunity and biological parameters in patients with chronic spontaneous urticaria.
de Montjoye L; Darrigade AS; Giménez-Arnau A; Herman A; Dumoutier L; Baeck M
Eur Ann Allergy Clin Immunol; 2021 Mar; 53(2):55-66. PubMed ID: 31965967
[No Abstract] [Full Text] [Related]
45. Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity.
Sabroe RA; Fiebiger E; Francis DM; Maurer D; Seed PT; Grattan CE; Black AK; Stingl G; Greaves MW; Barr RM
J Allergy Clin Immunol; 2002 Sep; 110(3):492-9. PubMed ID: 12209101
[TBL] [Abstract][Full Text] [Related]
46. Most Patients With Autoimmune Chronic Spontaneous Urticaria Also Have Autoallergic Urticaria, but Not ViceVersa.
Xiang YK; Kolkhir P; Scheffel J; Sauer M; Vera C; Frischbutter S; Krause K; Siebenhaar F; Metz M; Maurer M; Altrichter S
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2417-2425.e1. PubMed ID: 36805105
[TBL] [Abstract][Full Text] [Related]
47. Increased level of basophil CD203c expression predicts severe chronic urticaria.
Ye YM; Yang EM; Yoo HS; Shin YS; Kim SH; Park HS
J Korean Med Sci; 2014 Jan; 29(1):43-7. PubMed ID: 24431904
[TBL] [Abstract][Full Text] [Related]
48. Basophil CD63 expression assay on highly sensitized atopic donor leucocytes-a useful method in chronic autoimmune urticaria.
Gyimesi E; Sipka S; Dankó K; Kiss E; Hídvégi B; Gál M; Hunyadi J; Irinyi B; Szegedi A
Br J Dermatol; 2004 Aug; 151(2):388-96. PubMed ID: 15327546
[TBL] [Abstract][Full Text] [Related]
49. Eosinopenia, in Chronic Spontaneous Urticaria, Is Associated with High Disease Activity, Autoimmunity, and Poor Response to Treatment.
Kolkhir P; Church MK; Altrichter S; Skov PS; Hawro T; Frischbutter S; Metz M; Maurer M
J Allergy Clin Immunol Pract; 2020 Jan; 8(1):318-325.e5. PubMed ID: 31472293
[TBL] [Abstract][Full Text] [Related]
50. Detection of circulating IgG autoantibody to FcεRIα in sera from chronic spontaneous urticaria patients.
Ulambayar B; Chen YH; Ban GY; Lee JH; Jung CG; Yang EM; Park HS; Ye YM
J Microbiol Immunol Infect; 2020 Feb; 53(1):141-147. PubMed ID: 29169972
[TBL] [Abstract][Full Text] [Related]
51. Optimizing of the basophil activation test: Comparison of different basophil identification markers.
Eberlein B; Hann R; Eyerich S; Pennino D; Ring J; Schmidt-Weber CB; Buters J
Cytometry B Clin Cytom; 2015; 88(3):183-9. PubMed ID: 25399741
[TBL] [Abstract][Full Text] [Related]
52. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria.
Chang TW; Chen C; Lin CJ; Metz M; Church MK; Maurer M
J Allergy Clin Immunol; 2015 Feb; 135(2):337-42. PubMed ID: 24948369
[TBL] [Abstract][Full Text] [Related]
53. Basophils activation of patients with chronic spontaneous urticaria in response to C5a despite failure to respond to IgE-mediated stimuli.
Matsubara D; Yanase Y; Ishii K; Takahagi S; Tanaka A; Ozawa K; Hide M
Front Immunol; 2022; 13():994823. PubMed ID: 36248902
[TBL] [Abstract][Full Text] [Related]
54. STAP-2 positively regulates FcεRI-mediated basophil activation and basophil-dependent allergic inflammatory reactions.
Kashiwakura JI; Yamashita S; Yoshihara M; Inui K; Saitoh K; Sekine Y; Muromoto R; Kitai Y; Oritani K; Matsuda T
Int Immunol; 2019 Apr; 31(5):349-356. PubMed ID: 30726917
[TBL] [Abstract][Full Text] [Related]
55. Individual IL-3 priming is crucial for consistent in vitro activation of donor basophils in patients with chronic urticaria.
Gentinetta T; Pecaric-Petkovic T; Wan D; Falcone FH; Dahinden CA; Pichler WJ; Hausmann OV
J Allergy Clin Immunol; 2011 Dec; 128(6):1227-1234.e5. PubMed ID: 21855127
[TBL] [Abstract][Full Text] [Related]
56. Reactivity of human basophils to anti-IgE and protein A in atopic dermatitis.
Sainte-Laudy J; Henocq E
Agents Actions; 1990 Apr; 30(1-2):250-3. PubMed ID: 1695448
[TBL] [Abstract][Full Text] [Related]
57. IL-3 but not monomeric IgE regulates FcεRI levels and cell survival in primary human basophils.
Zellweger F; Buschor P; Hobi G; Brigger D; Dahinden CA; Villiger PM; Eggel A
Cell Death Dis; 2018 May; 9(5):510. PubMed ID: 29724998
[TBL] [Abstract][Full Text] [Related]
58. IgE and high-affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance.
Giménez-Arnau AM; Ribas-Llauradó C; Mohammad-Porras N; Deza G; Pujol RM; Gimeno R
Clin Transl Allergy; 2022 Feb; 12(2):e12117. PubMed ID: 35126995
[TBL] [Abstract][Full Text] [Related]
59. Mechanisms of autoimmune activation of basophils in chronic urticaria.
Kikuchi Y; Kaplan AP
J Allergy Clin Immunol; 2001 Jun; 107(6):1056-62. PubMed ID: 11398085
[TBL] [Abstract][Full Text] [Related]
60. Basophil responsiveness in chronic urticaria.
Saini SS
Curr Allergy Asthma Rep; 2009 Jul; 9(4):286-90. PubMed ID: 19656475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
